ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

Clinical trial NCT06345157 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06345157
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2024-07-30
Primary completion: 2026-06-30
Enrollment: 379

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.